骨赘和关节软骨的分子分化--瞬态和永久性软骨细胞表型的线索。
Molecular differentiation between osteophytic and articular cartilage--clues for a transient and permanent chondrocyte phenotype.
机构信息
Department of Orthopaedic Trauma Surgery, University Hospital Erlangen, Germany.
出版信息
Osteoarthritis Cartilage. 2012 Feb;20(2):162-71. doi: 10.1016/j.joca.2011.12.004. Epub 2011 Dec 13.
OBJECTIVE
To identify the molecular differences between the transient and permanent chondrocyte phenotype in osteophytic and articular cartilage.
METHODS
Total RNA was isolated from the cartilaginous layer of osteophytes and from intact articular cartilage from knee joints of 15 adult human donors and subjected to cDNA microarray analysis. The differential expression of relevant genes between these two cartilaginous tissues was additionally validated by quantitative reverse transcriptase polymerase chain reaction (RT-PCR) and by immunohistochemistry.
RESULTS
Among 47,000 screened transcripts, 600 transcripts were differentially expressed between osteophytic and articular chondrocytes. Osteophytic chondrocytes were characterized by increased expression of genes involved in the endochondral ossification process [bone gamma-carboxyglutamate protein/osteocalcin (BGLAP), bone morphogenetic protein-8B (BMP8B), collagen type I, alpha 2 (COL1A2), sclerostin (SOST), growth arrest and DNA damage-induced gene 45ß (GADD45ß), runt-related transcription factor 2 (RUNX2)], and genes encoding tissue remodeling enzymes [matrix metallopeptidase (MMP)9, 13, hyaluronan synthase 1 (HAS1)]. Articular chondrocytes expressed increased transcript levels of antagonists and inhibitors of the BMP- and Wnt-signaling pathways [Gremlin-1 (GREM1), frizzled-related protein (FRZB), WNT1 inducible signaling pathway protein-3 (WISP3)], as well as factors that inhibit terminal chondrocyte differentiation and endochondral bone formation [parathyroid hormone-like hormone (PTHLH), sex-determining region Y-box 9 (SOX9), stanniocalcin-2 (STC2), S100 calcium binding protein A1 (S100A1), S100 calcium binding protein B (S100B)]. Immunohistochemistry of tissue sections for GREM1 and BGLAP, the two most prominent differentially expressed genes, confirmed selective detection of GREM1 in articular chondrocytes and that of BGLAP in osteophytic chondrocytes and bone.
CONCLUSIONS
Osteophytic and articular chondrocytes significantly differ in their gene expression pattern. In articular cartilage, a prominent expression of antagonists inhibiting the BMP- and Wnt-pathway may serve to lock and stabilize the permanent chondrocyte phenotype and thus prevent their terminal differentiation. In contrast, osteophytic chondrocytes express genes with roles in the endochondral ossification process, which may account for their transient phenotype.
目的
鉴定骨赘和关节软骨中瞬态和永久软骨细胞表型的分子差异。
方法
从 15 位成人供体膝关节的骨赘软骨层和完整关节软骨中分离总 RNA,并进行 cDNA 微阵列分析。通过定量逆转录聚合酶链反应(RT-PCR)和免疫组织化学进一步验证这两种软骨组织中相关基因的差异表达。
结果
在筛选的 47000 个转录本中,有 600 个转录本在骨赘软骨细胞和关节软骨细胞之间表达差异。骨赘软骨细胞的特征是参与软骨内骨化过程的基因表达增加[骨γ-羧基谷氨酸蛋白/骨钙素(BGLAP)、骨形态发生蛋白 8B(BMP8B)、胶原 I,α 2(COL1A2)、硬化蛋白(SOST)、生长停滞和 DNA 损伤诱导基因 45β(GADD45β)、 runt 相关转录因子 2(RUNX2)]和编码组织重塑酶的基因[基质金属蛋白酶(MMP)9、13、透明质酸合酶 1(HAS1)]。关节软骨细胞表达 BMP 和 Wnt 信号通路拮抗剂和抑制剂的转录本水平增加[Gremlin-1(GREM1)、卷曲相关蛋白(FRZB)、WNT1 诱导信号通路蛋白 3(WISP3)],以及抑制终末软骨细胞分化和软骨内骨形成的因子[甲状旁腺激素样激素(PTHLH)、性别决定区 Y 盒 9(SOX9)、成纤维细胞生长因子 23(FGF23)、硬骨素 2(STC2)、S100 钙结合蛋白 A1(S100A1)、S100 钙结合蛋白 B(S100B)]。组织切片免疫组织化学分析 GREM1 和 BGLAP 这两个最显著差异表达的基因,证实了 GREM1 在关节软骨细胞中的选择性检测和 BGLAP 在骨赘软骨细胞和骨中的检测。
结论
骨赘和关节软骨细胞的基因表达模式存在显著差异。在关节软骨中,抑制 BMP 和 Wnt 通路的拮抗剂的显著表达可能用于锁定和稳定永久软骨细胞表型,从而阻止其终末分化。相比之下,骨赘软骨细胞表达参与软骨内骨化过程的基因,这可能是其瞬态表型的原因。